Detection of novel and potentially actionable anaplastic lymphoma kinase (<i>ALK</i>) rearrangement in colorectal adenocarcinoma by immunohistochemistry screening
Jeeyun Lee(Sungkyunkwan University), Sai‐Hong Ignatius Ou(University of California, Irvine Medical Center)
Cited by 37
Related Papers
Crizotinib: a novel and first-in-class multitargeted tyrosine kinase inhibitor for the treatment of anaplastic lymphoma kinase rearranged nonsmall cell lung cancer and beyond
|Drug Design Development and Therapy|2011|182
Gastrointestinal malignancies harbor actionable MET exon 14 deletions
|Oncotarget|2015|61
<i>NTRK1</i> rearrangement in colorectal cancer patients: evidence for actionable target using patient-derived tumor cell line
|Oncotarget|2015|58
Comprehensive pharmacogenomic characterization of gastric cancer
|Genome Medicine|2020|55